---
title: "Exelixis director Mary C Beckerle disposes of 9,812 shares worth $526,908.92"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295720925.md"
description: "Exelixis director Mary C. Beckerle sold 9,812 common shares on August 10, 2026, at $53.66 per share, totaling $526,908.92. Following the transaction, her beneficial ownership stands at 16,079 shares."
datetime: "2026-08-12T23:34:42.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295720925.md)
  - [en](https://longbridge.com/en/news/295720925.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295720925.md)
generator: "portal-rs"
---

# Exelixis director Mary C Beckerle disposes of 9,812 shares worth $526,908.92

-   Exelixis director Mary C. Beckerle sold 9,812 common shares on Aug. 10, 2026 at USD 53.66. \* Beneficial ownership reported as 16,079 shares following the transaction. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Exelixis Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000939767-26-000101), on August 12, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [EXEL.US](https://longbridge.com/en/quote/EXEL.US.md)

## Related News & Research

- [Exelixis Stock Slips as FDA Delays Cancer Drug Review, Analyst Weighs In](https://longbridge.com/en/news/298761132.md)
- [Exelixis NDA review for zanzalintinib plus atezolizumab extended; PDUFA date moved to Mar 3, 2027](https://longbridge.com/en/news/298721674.md)
- [Phinia CFO Chris P. Gropp sells 13,500 shares for $900,536.40](https://longbridge.com/en/news/298765805.md)
- [Intuitive Surgical EVP and Chief Manufacturing and Supply Chain Mark Brosius sells USD 24,222.38 in common shares](https://longbridge.com/en/news/298511449.md)
- [BOFH: Oh no! The CMS ate 500 pages of corporate documentation](https://longbridge.com/en/news/298702240.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**